Bird and Be Raises $13 Million in Latest Funding Round
Toronto-based Bird and Be, a company specializing in clinically-backed prenatal vitamins and at-home tests, announced a successful funding round on September 22, 2026, securing $13 million. The round was led by BDC Thrive and BFG Partners, with participation from BAM Ventures, Founder Collective, Rejuvenation Ventures, and HSR Ventures.
Company Mission and Offerings
Bird and Be provides doctor-approved prenatal vitamins and at-home tests designed to support both females and males on their journey to parenthood. These products are trusted by medical professionals and naturopaths for their reliability and convenience.
Leadership Team
The company was co-founded by Samantha Diamond, who serves as the CEO, and Shannon Gallagher, the Chief Growth Officer. Under their leadership, Bird and Be has focused on making fertility and prenatal health more accessible and convenient for prospective parents.
Strategic Plans for the New Funding
While specific details on the allocation of the new funds were not disclosed, the investment is expected to support the expansion of Bird and Be's product offerings and market reach. The infusion of capital will likely enhance research and development initiatives and improve customer access to their products.
Investor Confidence
BDC Thrive and BFG Partners' involvement as lead investors highlights a strong vote of confidence in Bird and Be's innovative approach to reproductive health. The participation of other notable investors such as BAM Ventures, Founder Collective, Rejuvenation Ventures, and HSR Ventures further underscores the potential seen in the company's business model.